Scholarlink

Background <p>Crohn’s disease (CD) exhibits substantial heterogeneity in disease behavior and therapeutic outcomes across distinct disease locations. Specific alterations in the gut microbiota and metabolites may drive this variation. This review aims to characterize the distinctive microbial and metabolic signatures across CD phenotypes based on disease location.</p> Methods <p>Electronic databases were searched from inception to December 2025 for studies that observed alterations in gut microbiota and metabolites in CD patients with different disease locations.</p> Results <p>Forty-eight studies including 3,577 CD patients and 2,916 healthy controls (HCs) were analyzed. Ileal Crohn’s disease (ICD) was characterized by significant dysbiosis compared with HCs, featuring enrichment of <i>Enterobacteriaceae</i> (especially adherent-invasive <i>Escherichia coli</i> [AIEC]), <i>Fusobacterium</i> and <i>Shigella</i>, alongside depletion of <i>Faecalibacterium prausnitzii</i>, <i>Roseburia</i> and <i>Coprococcus</i>. Patients with colonic Crohn’s disease (CCD) exhibited increased levels of <i>Proteobacteria</i>, pro-inflammatory families (<i>Actinomycetaceae</i>, <i>Micrococcaceae</i>) and opportunistic pathogens (<i>Streptococcus</i>, <i>Klebsiella</i>). In contrast, a decrease in short-chain fatty acid (SCFA)-producing families (<i>Lachnospiraceae</i>, <i>Ruminococcaceae</i>) and <i>F. prausnitzii</i> was observed in CCD. Ileocolonic Crohn’s disease (ICCD) displayed features combining ICD and CCD elements, with specific depletion in <i>Alistipes communis</i> and enrichment of <i>Shigella flexneri</i>. More pro-inflammatory bacteria were observed in ICD compared with CCD. In terms of metabolic alterations, ICD showed impaired enterohepatic bile acid circulation with excessive fecal loss of conjugated bile acids, while CCD exhibited defective conversion of primary to secondary bile acids. ICCD exhibited both impaired ileal reabsorption and defective colonic transformation.</p> Conclusions <p>Our results identified disease location-specific alterations in the microbiome and metabolome of CD, which might be associated with the clinical manifestations and prognosis of different phenotypes.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Specific alterations in the gut microbiome and metabolome across disease locations of Crohn’s disease: a systematic review

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月11日

查看全文
  • Jieqing Huang,
  • Zihan Chen,
  • Mengqi Chen,
  • Zhirong Zeng,
  • Xiaojun Zhuang

摘要

Background

Crohn’s disease (CD) exhibits substantial heterogeneity in disease behavior and therapeutic outcomes across distinct disease locations. Specific alterations in the gut microbiota and metabolites may drive this variation. This review aims to characterize the distinctive microbial and metabolic signatures across CD phenotypes based on disease location.

Methods

Electronic databases were searched from inception to December 2025 for studies that observed alterations in gut microbiota and metabolites in CD patients with different disease locations.

Results

Forty-eight studies including 3,577 CD patients and 2,916 healthy controls (HCs) were analyzed. Ileal Crohn’s disease (ICD) was characterized by significant dysbiosis compared with HCs, featuring enrichment of Enterobacteriaceae (especially adherent-invasive Escherichia coli [AIEC]), Fusobacterium and Shigella, alongside depletion of Faecalibacterium prausnitzii, Roseburia and Coprococcus. Patients with colonic Crohn’s disease (CCD) exhibited increased levels of Proteobacteria, pro-inflammatory families (Actinomycetaceae, Micrococcaceae) and opportunistic pathogens (Streptococcus, Klebsiella). In contrast, a decrease in short-chain fatty acid (SCFA)-producing families (Lachnospiraceae, Ruminococcaceae) and F. prausnitzii was observed in CCD. Ileocolonic Crohn’s disease (ICCD) displayed features combining ICD and CCD elements, with specific depletion in Alistipes communis and enrichment of Shigella flexneri. More pro-inflammatory bacteria were observed in ICD compared with CCD. In terms of metabolic alterations, ICD showed impaired enterohepatic bile acid circulation with excessive fecal loss of conjugated bile acids, while CCD exhibited defective conversion of primary to secondary bile acids. ICCD exhibited both impaired ileal reabsorption and defective colonic transformation.

Conclusions

Our results identified disease location-specific alterations in the microbiome and metabolome of CD, which might be associated with the clinical manifestations and prognosis of different phenotypes.